Dublin, April 11, 2018 -- The "Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022)" report has been added to ResearchAndMarkets.com's offering.
The global Animal Antibiotics & Antimicrobials industry has been driven by the rising demand for animal derived food products and increasing healthcare expenditure on pets due to rising pet ownership. Globally, the growth in Animal Antibiotics & Antimicrobials market is driven by growing middle class population.
Global market is projected to display a robust growth represented by a CAGR of 4.24% by value during 2017 - 2022, chiefly driven by increase in animal population and rising trend of pet ownership among growing middle class income group coupled with rising awareness of animal health.
Among the type, Tetracycline accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large animal population base, growing trend of pet humanization and expanding middle class income group.
Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Global Animal Antibiotics and Antimicrobials Market, By Value
- By Product Type - Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins and Others)
- By Delivery Type - Premixes, Oral Powder, Oral Solution, Injections, Others
- By Delivery Type - Premixes, Oral Powder, Oral Solution, Injections, Others
- By Type of Animals - Farm Animals, Companion Animals
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Global Antibiotics & Antimicrobials Product Outlook
5. Global Antibiotics & Antimicrobials Market: Growth and Forecast
5.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
5.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
5.3. Global Antibiotics & Antimicrobials & Market - By Product Type, By Value
5.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
5.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
5.4. Global Antibiotics & Antimicrobials & Market - By Product Type, By Value (2012-2022)
5.4.1. Penicillins, By Value (2012-2022)
5.4.2. Fluoroquinolones, By Value (2012-2022)
5.4.3. Aminoglycosides, By Value (2012-2022)
5.4.4. Tetracyclines, By Value (2012-2022)
5.4.5. Macrolides, By Value (2012-2022)
5.4.6. Sulfonamides, By Value (2012-2022)
5.4.7. Lincosamides, By Value (2012-2022)
5.4.8. Cephalosporins, By Value (2012-2022)
5.4.9. Others, By Value (2012-2022)
5.5. Global Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
5.5.1. Farm Animals, By Value (2012-2022)
5.5.2. Companion Animals, By Value (2012-2022)
5.6. Global Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
5.6.1. Premixes, By Value (2012-2022)
5.6.2. Oral Powder, By Value (2012-2022)
5.6.3. Oral Solution, By Value (2012-2022)
5.6.4. Injections , By Value (2012-2022)
5.6.5. Others, By Value (2012-2022)
6. North America Antibiotics & Antimicrobials Market: Growth and Forecast
7. Europe Antibiotics & Antimicrobials Market: Growth and Forecast
8. Asia-Pacific Antibiotics & Antimicrobials Market: Growth and Forecast
9. Rest of Asia-Pacific Antibiotics & Antimicrobials Market, By Value (2017-2022)
9.1. Rising demand for meat heavy diet and Animal derived products
9.2. Increasing ownership and rising spending on pets
9.3. Increasing risk of Animal Borne infectious Diseases
10. Market Restraints
11. Consolidation of the Industry
12. Porter's Five Forces Analysis - Heart Valve Devices Market
13. SWOT Analysis -Heart Valve Devices Market
14. Policy and Regulations
15. Company Profiles
- Bayer AG
- Boehringer Ingelheim GmbH
- Ceva Sante Animale
- Dechra Pharmaceuticals PLC
- Eli Lilly and Company
- Merck & Co. Inc.
- Phibro Animal Health Corporation
- Vetoquinol S.A.
- Virbac
- Zoetis Inc.
For more information about this report visit https://www.researchandmarkets.com/research/j6hspt/global_animal?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Animal Healthcare/Veterinary, Animal Pharmaceuticals


AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
How Marco Pharma International Preserves German Homeopathic Traditions in America
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 



